Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06802133 · ClinicalTrials.gov registry record
Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)
A clinical trial of Repair of Dura Mater, sponsored by Collagen Matrix.
- Recruiting
- Registry status
- 118
- Enrollment target
- 2
- Study locations
NCT06802133: Recruiting study of Repair of Dura Mater, sponsored by Collagen Matrix.
NCT06802133 is a study of Repair of Dura Mater that is actively recruiting participants, run by Collagen Matrix. The registered enrollment target is 118 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06802133, a study of Repair of Dura Mater, is actively recruiting participants, sponsored by Collagen Matrix.
- RECRUITING
- Registry status
- 118 participants
- Enrollment target
- 2
- Study locations
Study Summary
Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
Primary Outcome
Adequate healing of dural defects without need for a revision surgery or second intervention
Conditions Studied
Interventions
- OTHER Post Market Study
Study Locations (2)
Georgia
- Augusta University - Augusta
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2026-07-30 |
What NCT06802133 shows while recruiting
NCT06802133 is an observational study that tracks outcomes without assigning an intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Repair of Dura Mater appearing as the primary indexed condition, and to 1 intervention - of which Post Market Study is the first listed.
NCT06802133 reports a single indexed study location in Georgia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06802133 about?
NCT06802133 is a clinical study titled "Post-Market Clinical Investigation Plan- Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus)". Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
What is the current status of trial NCT06802133?
This trial is currently recruiting. The enrollment target is 118 participants. The study started on 2025-01-13. Estimated completion is 2026-07-30.
What conditions does trial NCT06802133 study?
This clinical trial studies the following conditions: Repair of Dura Mater.
What interventions are being tested in trial NCT06802133?
The interventions under investigation include: Post Market Study (OTHER).
Who is sponsoring clinical trial NCT06802133?
This trial is sponsored by Collagen Matrix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06802133 being conducted?
This trial has 2 study locations across Georgia, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Repair of Dura Mater
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI